Neoantigen Targeted Therapies Market is estimated to be worth USD 3 Billion in 2030
Advances in bioinformatics and genomic data analysis have enabled the identification of cancer antigens that are generally overlooked during immune surveillance; these neoantigens have been shown to possess substantial therapeutic potential Roots Analysis is pleased to announce the publication of its recent study, titled, “Neoantigen Targeted Therapies, 2019-2030.” The report...
0 Reacties 0 aandelen